Maharashtra Herald

Biobanking Market to Witness an Outstanding Growth by 2025

 Breaking News
  • No posts were found

Biobanking Market to Witness an Outstanding Growth by 2025

September 12
15:03 2019
Biobanking Market to Witness an Outstanding Growth by 2025

Biobanking Market
Increase in incidence of chronic disease such as cancer bolsters the market of biobanking. Since the use of conventional therapies have serious side-effects, integrating it with stem cell therapy reduces the damage and hence the increased demand.

Biobanking refers to the process in which biological samples are collected and stored for research and clinical care. The major factors that contribute towards the market growth include rise in funding by private & government organizations for biobanking and increase in application areas of biobanked samples. Biobanked specimens are used in the treatment of several chronic diseases, and thus increase in incidence of disease such as cancer further supports the market growth. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. Conversely, unmet medical needs in the emerging nations are expected to provide lucrative opportunity for the market.

Global biobanking market share was valued at $47,062 million in 2017, and is estimated to reach $68,084 million by 2025, growing at a CAGR of 4.6% from 2017 to 2025.

Download Report Sample: https://www.alliedmarketresearch.com/request-sample/2798

The blood product segment generated the maximum revenue in 2017, accounting for more than two-fifths share of the global biobanking market in 2017. On the other hand, solid tissue segment is expected to witness the highest CAGR during the forecast period.

By type of biobank, the disease-based biobank segment generated the maximum revenue in 2017 and population-based biobank segment is expected to grow at a CAGR of 5.2% during the forecast period.

Key Findings of the Biobanking Market:

• The research segment contributed for nearly two-thirds share of the global biobanking market in 2017.
• The private organization segment is projected to grow at a significant CAGR from 2018 to 2025.
• In 2017, national/regional agencies led the overall biobanking market, and is projected to grow at a CAGR of 4.2% during the forecast period.
• Germany and France are the major shareholders, which collectively accounted for more than one-third share of the Europe biobanking market in 2017.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific biobanking market in 2017.

Europe market is projected to dominate the global biobanking market in terms of revenue during the forecast period. This is majorly due to the increase in number of biobanks in the region coupled with increasing research activities related to biobanking. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR of 5.7% during the forecast period.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2798

The major companies profiled in the report are ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions, Inc., LGC Limited, PrecisionMed, Inc., and ProMedDx LLC.

Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States
Website: www.alliedmarketresearch.com/biobanking-market

Calendar

September 2019
M T W T F S S
« Aug    
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Categories